Estrogen Receptor Antibody (DA155)
IHC (FFPE)
Description
ER is a nuclear hormone receptor that activates transcription of various genes, especially in reproductive tissues, regulated by its ligand estrogen. The antibody stains nuclei of cells with high levels of ER, e.g. epithelial cells and carcinoma of breast, uterus, ovary, and prostate. ER is expressed in approximately 75 % of all breast cancer cases. It is reported that patients with ERpositive tumors have better prognosis than patients with ERnegative tumors. The stated antibody may be helpful in detection of breast carcinoma. 1-3 — Références — 1. Lim E, Tarulli G, Portman N, et al. (2016): Pushing estrogen receptor around in breast cancer. Endocr Relat Cancer. 23(12): T227-T241. 2. Farzaneh S, & Zarghi A (2016): Estrogen Receptor Ligands: A Review (2013-2015). Sci Pharm. 84(3):409-427. 3. Gown AM (2008): Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol. 21 Suppl 2:S8-S15.
Caractéristiques
- Type
- Recombinant monoclonal rabbit antibody
- Clone
- DA155
- Isotype
- Rabbit
- Réactivité
- Synthetic peptide of human ER
- Localisation
- Nucleus
- Usage prévu
- IHC (FFPE)
Conditionnements disponibles
2 référence(s) catalogue.
| N° catalogue | Type | Dilution | Volume | |
|---|---|---|---|---|
| DMRD0191 | Concentrate | 1:100 – 1:300 | 0.1ml, 0.5ml, 1ml | Demander un devis → |
| DMRD0191 | Ready to use | 1:100 – 1:300 | 3ml, 6ml, 10ml | Demander un devis → |
Intéressé par ce produit ?
Indiquez la référence et le conditionnement souhaités, nous revenons vers vous rapidement.
Dartmon